Видео с ютуба V600E

What is a BRAF-V600E mutation?

How BRAF V600E-Mutated CRC is Treated Differently Than Other Cancers

Мутации BRAF V600E и TERT при ПРЩЖ: клинико-патологические аспекты с доктором Накашимой

Why is it so important to know if you have BRAF-V600E?

Treating BRAF V600E-mutant NSCLC with dabrafenib and trametinib

Treatment approaches for BRAF V600E mutant metastatic colorectal cancer

Breakthrough in BRAF V600E mCRC treatment: new first-line therapy emerges

Encorafenib + cetuximab (EC) BREAKWATER Study in BRAF V600E-Mutant Metastatic Colorectal Cancer

Encorafenib, cetuximab plus chemotherapy yields good response in BRAF V600E mCRC

Real-World Management of Patients with BRAF-V600E mCRC

BEACON Trial: Triplet Therapy in BRAF V600E–Mutated mCRC

Evaluating the prevalence of BRAF V600E mutations in glioblastoma

The evolving treatment paradigm for BRAF V600E-mutant mCRC

BREAKWATER Study from GI ASCO 2025 in BRAF V600E Tumors

Intrathoracic Synovial Sarcoma with BRAF V600E Mutation | Oncotarget

Targeted Therapies for BRAF V600E-Mutated mNSCLC

Ulixertinib in tumors with BRAF fusions, non-V600E or non-V600K BRAF mutations

BRAF Mutation in Thyroid Cancer | UCLA Endocrine Center

Dr. Long on Dabrafenib/Trametinib in BRAF V600E-Mutant Melanoma

Влияние статуса BRAF V600E на смертность при посттравматическом раке щитовидной железы, связанную...

Dr. Lieu on the Predictive Value of BRAF V600E Mutations in CRC

BRAF V600E As A Target In Advanced Non Small Cell Lung Cancer

Combination therapies with vemurafenib in BRAF v600E–mutant cancers

Colorectal Cancer Debate: First Line BRAF V600E - FOLFOXIRI/Bev

Novel treatment strategies for BRAF V600E-mutant NSCLC